Literature DB >> 2868286

Effect of etomidate on hypercortisolism due to ectopic ACTH production.

R Gärtner, M Albrecht, O A Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2868286     DOI： 10.1016/s0140-6736(86)90811-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.

Authors:  Jens Heyn; Carolin Geiger; Christian L Hinske; Josef Briegel; Florian Weis
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

2.  Treatment of severe psychosis due to ectopic Cushing's syndrome.

Authors:  Y M Bilgin; H E van der Wiel; H R Fischer; W W De Herder
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

Review 3.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Authors:  B M K Biller; A B Grossman; P M Stewart; S Melmed; X Bertagna; J Bertherat; M Buchfelder; A Colao; A R Hermus; L J Hofland; A Klibanski; A Lacroix; J R Lindsay; J Newell-Price; L K Nieman; S Petersenn; N Sonino; G K Stalla; B Swearingen; M L Vance; J A H Wass; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

4.  Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome.

Authors:  B Allolio; H M Schulte; D Kaulen; M Reincke; C Jaursch-Hancke; W Winkelmann
Journal:  Klin Wochenschr       Date:  1988-04-15

Review 5.  Pharmacological management of severe Cushing's syndrome: the role of etomidate.

Authors:  Andrea Pence; Megan McGrath; Stephanie L Lee; Douglas E Raines
Journal:  Ther Adv Endocrinol Metab       Date:  2022-02-14       Impact factor: 3.565
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.